MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 280 filers reported holding MYRIAD GENETICS INC in Q3 2014. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $6,583,000 | +2.2% | 229,925 | -0.8% | 3.27% | +7.4% |
| Q2 2019 | $6,441,000 | -16.7% | 231,875 | -0.5% | 3.04% | -14.8% |
| Q1 2019 | $7,735,000 | -64.4% | 232,975 | -62.1% | 3.57% | +20.2% |
| Q1 2015 | $21,745,000 | -0.3% | 614,275 | -4.1% | 2.97% | +2.3% |
| Q4 2014 | $21,811,000 | -13.5% | 640,375 | -2.1% | 2.91% | -18.5% |
| Q3 2014 | $25,218,000 | -4.3% | 653,825 | -3.4% | 3.57% | +8.8% |
| Q2 2014 | $26,338,000 | +11.8% | 676,725 | -1.7% | 3.28% | +12.2% |
| Q1 2014 | $23,548,000 | +60.4% | 688,725 | -1.5% | 2.92% | +61.9% |
| Q4 2013 | $14,677,000 | -26.9% | 699,550 | -18.1% | 1.80% | -12.5% |
| Q3 2013 | $20,080,000 | – | 854,475 | – | 2.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
| Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
| ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
| OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
| EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
| AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
| Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
| Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |